MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
275.23
-3.20
-1.15%
After Hours: 276.53 +1.3 +0.47% 19:59 09/04 EDT
OPEN
275.13
PREV CLOSE
278.43
HIGH
277.80
LOW
274.75
VOLUME
4.32M
TURNOVER
--
52 WEEK HIGH
281.07
52 WEEK LOW
169.51
MARKET CAP
663.28B
P/E (TTM)
31.91
1D
5D
1M
3M
1Y
5Y
1D
If the Fed Hikes Interest Rates This Month, History Says This Is the Smartest ETF to Buy Right Now
The Motley Fool · 9h ago
Does IMAAVY’s Approval and Ongoing Talc Verdict Meaningfully Shift the Bull Case for Johnson & Johnson (JNJ)?
Simply Wall St · 23h ago
Tyra Biosciences: 'Hold' IR-NMIBC Data September 9th 2026, With Caution Ahead For 2027 Readouts
Seeking Alpha · 1d ago
Wall Street Week Ahead
Seeking Alpha · 1d ago
Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning?
The Motley Fool · 1d ago
Insider trades: Nvidia, TSMC, and Johnson & Johnson among notable names
Seeking Alpha · 2d ago
Nvidia, TSMC, Salesforce, CrowdStrike, J&J Insider Shake‑Up
TipRanks · 2d ago
Top Johnson & Johnson Executive Makes Major Stock Move
TipRanks · 2d ago
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. Its segments include Innovative Medicine and MedTech. The Innovative Medicine segment focuses on various therapeutic areas, oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases and cardiovascular and metabolism. Its products include CARVYKTI (ciltacabtagene autoleucel), DARZALEX (daratumumab), DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), ERLEADA (apalutamide), among others. The MedTech segment develops and manufactures a broad portfolio of products used in cardiovascular, orthopedics, surgery, and vision supporting physicians, hospitals, eye care professionals and healthcare systems across a range of acute and elective procedures. The Cardiovascular portfolio includes electrophysiology products. It is also focused on proprietary Firelink degrader antibody conjugate platform.

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.